Streptococcus pneumoniae causante de enfermedad neumocócica invasivas en adultos. Paraguay (2013-2018)
Autor: | Aníbal Kawabata, Gloria Gómez, María Eugenia León, Helena Ortiz, Liliana Rojas, Gustavo Chamorro, Rossana Franco, Nancy Segovia, Juan Irala, Minako Nagai, Miriam Leguizamón |
---|---|
Jazyk: | Spanish; Castilian |
Rok vydání: | 2018 |
Předmět: |
Serotype
medicine.medical_specialty Population enfermedad neumocócica invasiva invasive pneumococcal disease Sepsis Internal medicine adults medicine Blood culture education lcsh:Science (General) education.field_of_study medicine.diagnostic_test adultos business.industry General Medicine enfermedadneumocócicainvasiva medicine.disease Antimicrobial Penicillin Pneumonia Streptococcus pneumoniae Paraguay lcsh:TA1-2040 business lcsh:Engineering (General). Civil engineering (General) Meningitis medicine.drug lcsh:Q1-390 |
Zdroj: | Revista de la Sociedad Científica del Paraguay, Vol 23, Iss 2, Pp 263-274 (2018) Revista de la Sociedad Científica del Paraguay, Volume: 23, Issue: 2, Pages: 263-274, Published: DEC 2018 |
ISSN: | 2617-4731 0379-9123 2013-2018 |
Popis: | Resumen Se describe la frecuencia de aislamientos de S. pneumoniae causante de enfermedad neumocócica invasiva (ENI) en adultos, la distribución de los serotipos y su sensibilidad antimicrobiana en Paraguay durante el periodo 2013-2018. Se trata de un estudio descriptivo observacional retrospectivo de corte transversal en el que se estudiaron un total de 269 cepas de S. pneumoniae aisladas en líquido cefalorraquídeo (LCR) (76/269), líquido pleural (174/269) y hemocultivo 19/269), provenientes de los diferentes centros centinelas y colaboradores de la vigilancia de meningitis y neumonías bacterianas en Paraguay durante el periodo 2013 a setiembre de 2018. Se halló que el 28.0% de los casos correspondieron a meningitis bacteriana aguda (MBA) (76/269), 65.0% a neumonías (174/269) y 7.0% a sepsis (19/269). Se observó una mayor frecuencia de casos en adultos mayores de 60 años en MBA 29.0%, en neumonías 46.0% y en sepsis 42.0%. Los serotipos más frecuentes fueron el 3 con 13.0% (34/269), el 19A 10.0% (26/269), el 14 con 5.0% (12/269), el 12F con 4.0% (11/269) y los NT con 6.0% (16/269). Se encontraron 43/269 (15.0%) serotipos incluidos en la PCV10, 118/269 (44.0%) incluidos en la PCV13 y 165/269 (61.0%) incluidos en la PCV23. En los casos de meningitis se detectaron 20 aislamientos de S. pneumoniae resistentes a penicilina (38.5%). Se concluye que es necesaria una vigilancia epidemiológica continua para evaluar la carga de enfermedad y medir la efectividad de la vacuna en esta población para comprender la plena magnitud de la ENI en Paraguay, incluyendo su impacto económico, y definir estrategias eficaces para prevenirla. Abstract Aim. Describe the frequency of S. pneumoniae isolates that cause invasive pneumococcal disease (ENI) in adults, the distribution of serotypes and their antimicrobial sensitivity in Paraguay during the period 2013-2018. The approach conforms a cross-sectional retrospective observational descriptive study in which a total of 269 strains of S. pneumoniae isolated in cerebrospinal fluid (CSF) (76/269), pleural fluid (174/269) and blood culture 19/269) were studied. the different sentinel centers and collaborators of the surveillance of bacterial meningitis and pneumonias in Paraguay during the period 2013 to September 2018. It was found that 28.0% of the cases corresponded to acute bacterial meningitis (MBA) (76/269), 65.0% to pneumonias (174/269) and 7.0% to sepsis (19/269). A higher frequency of cases was observed in adults over 60 years of age in MBA 29.0%, in pneumonia 46.0% and in sepsis 42.0%. The most frequent serotypes were 3 with 13.0% (34/269), 19A 10.0% (26/269), 14 with 5.0% (12/269), 12F with 4.0% (11/269) and NT with 6.0% (16/269). We found 43/269 (15.0%) serotypes included in PCV10, 118/269 (44.0%) included in PCV13 and 165/269 (61.0%) included in PCV23. In the cases of meningitis, they were detected 20 isolates of S. pneumoniae resistant to penicillin (38.5%). It can be conclude that continuous epidemiological surveillance is needed to assess the burden of disease and measure the impact of the vaccine in this population to understand the full magnitude of the ENI in Paraguay, including its economic impact, and define effective strategies to prevent it. |
Databáze: | OpenAIRE |
Externí odkaz: |